Singapore markets open in 3 hours 6 minutes

Straits Times Index
3,179.58
-15.46(-0.48%)
S&P 500
3,978.73
+37.25(+0.95%)
Dow
32,120.28
+191.66(+0.60%)
Nasdaq
11,434.74
+170.29(+1.51%)
BTC-USD
29,781.04
+231.69(+0.78%)
CMC Crypto 200
659.93
-11.08(-1.65%)

BioCryst Pharmaceuticals, Inc. (BCRX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Add to watchlist

8.80

+0.23

(+2.68%)

At close: 04:00PM EDT

8.72

-0.08

(-0.91%)

After hours:

05:25PM EDT

Loading interactive chart…

Motley Fool
Why BioCryst Stock Lost Nearly 4% of Its Value Today
The biotech whiffs on both revenue and profitability for its first quarter, and indicates more losses are in store.
Motley Fool
BioCryst Pharmaceuticals (BCRX) Q1 2022 Earnings Call Transcript
Image source: The Motley Fool. BioCryst Pharmaceuticals (NASDAQ: BCRX)Q1 2022 Earnings CallMay 05, 2022, 8:30 a.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorGood day, and thank you for standing by.
Zacks
BioCryst Pharmaceuticals (BCRX) Reports Q1 Loss, Lags Revenue Estimates
BioCryst (BCRX) delivered earnings and revenue surprises of -2.56% and 1.33%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?